메뉴 건너뛰기




Volumn 84, Issue 2, 2012, Pages 369-375

Analysis of dosimetric parameters associated with acute gastrointestinal toxicity and upper gastrointestinal bleeding in locally advanced pancreatic cancer patients treated with gemcitabine-based concurrent chemoradiotherapy

Author keywords

Acute gastrointestinal toxicity; Dose toxicity relationship; Gemcitabine based chemoradiotherapy; Pancreatic cancer; Upper gastrointestinal bleeding

Indexed keywords

ADVERSE EVENTS; CONCURRENT CHEMORADIOTHERAPY; DOSE-TOXICITY RELATIONSHIP; DOSIMETRIC PARAMETER; GASTROINTESTINAL TOXICITIES; GEMCITABINE; INTENSITY-MODULATED RADIOTHERAPY; MEAN DOSE; NOVEL TECHNIQUES; PANCREATIC CANCERS; PLANNING TARGET VOLUMES; PREDICTIVE FACTORS; SMALL INTESTINE; UNIVARIATE ANALYSIS; UPPER GASTROINTESTINAL;

EID: 84865627118     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.12.026     Document Type: Article
Times cited : (63)

References (13)
  • 1
    • 33645714531 scopus 로고    scopus 로고
    • Chemoradiotherapy in patients with pancreatic carcinoma: Phase-I study with a fixed radiation dose and escalating doses of weekly gemcitabine
    • N. Oya, K. Shibuya, and T. Sakamoto Chemoradiotherapy in patients with pancreatic carcinoma: Phase-I study with a fixed radiation dose and escalating doses of weekly gemcitabine Pancreatology 6 2006 109 116
    • (2006) Pancreatology , vol.6 , pp. 109-116
    • Oya, N.1    Shibuya, K.2    Sakamoto, T.3
  • 2
    • 79955969176 scopus 로고    scopus 로고
    • Phase II study of radiation therapy combined with weekly low-dose gemcitabine for locally advanced, unresectable pancreatic cancer
    • K. Shibuya, N. Oya, and T. Fujii Phase II study of radiation therapy combined with weekly low-dose gemcitabine for locally advanced, unresectable pancreatic cancer Am J Clin Oncol 34 2011 115 119
    • (2011) Am J Clin Oncol , vol.34 , pp. 115-119
    • Shibuya, K.1    Oya, N.2    Fujii, T.3
  • 3
    • 0019410935 scopus 로고
    • Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group
    • C.G. Moertel, S. Frytak, and R.G. Hahn Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group Cancer 48 1981 1705 1710
    • (1981) Cancer , vol.48 , pp. 1705-1710
    • Moertel, C.G.1    Frytak, S.2    Hahn, R.G.3
  • 4
    • 0034306137 scopus 로고    scopus 로고
    • Eastern Cooperative Oncology Group phase i trial of protracted venous infusion fluorouracil plus weekly gemcitabine with concurrent radiation therapy in patients with locally advanced pancreas cancer: A regimen with unexpected early toxicity
    • M.S. Talamonti, P.J. Catalano, and D.J. Vaughn Eastern Cooperative Oncology Group phase I trial of protracted venous infusion fluorouracil plus weekly gemcitabine with concurrent radiation therapy in patients with locally advanced pancreas cancer: A regimen with unexpected early toxicity J Clin Oncol 18 2000 3384 3389
    • (2000) J Clin Oncol , vol.18 , pp. 3384-3389
    • Talamonti, M.S.1    Catalano, P.J.2    Vaughn, D.J.3
  • 5
    • 0036534672 scopus 로고    scopus 로고
    • Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?
    • C.H. Crane, J.L. Abbruzzese, and D.B. Evans Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer? Int J Radiat Oncol Biol Phys 52 2002 1293 1302
    • (2002) Int J Radiat Oncol Biol Phys , vol.52 , pp. 1293-1302
    • Crane, C.H.1    Abbruzzese, J.L.2    Evans, D.B.3
  • 6
    • 34249332089 scopus 로고    scopus 로고
    • Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer
    • J.D. Murphy, S. Adusumilli, and K.A. Griffith Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer Int J Radiat Oncol Biol Phys 68 2007 801 808
    • (2007) Int J Radiat Oncol Biol Phys , vol.68 , pp. 801-808
    • Murphy, J.D.1    Adusumilli, S.2    Griffith, K.A.3
  • 7
    • 76449104629 scopus 로고    scopus 로고
    • Radiation dose-volume effects in the stomach and small bowel
    • B.D. Kavanagh, C.C. Pan, and L.A. Dawson Radiation dose-volume effects in the stomach and small bowel Int J Radiat Oncol Biol Phys 76 3 Suppl. 2010 S101 S107
    • (2010) Int J Radiat Oncol Biol Phys , vol.76 , Issue.3 SUPPL.
    • Kavanagh, B.D.1    Pan, C.C.2    Dawson, L.A.3
  • 8
    • 77956890008 scopus 로고
    • Martingale-based residuals for survival models
    • T.M. Therneau, P.M. Grambsch, and T.R. Fleming Martingale-based residuals for survival models Biometrika 77 1990 147 160
    • (1990) Biometrika , vol.77 , pp. 147-160
    • Therneau, T.M.1    Grambsch, P.M.2    Fleming, T.R.3
  • 9
    • 0034548078 scopus 로고    scopus 로고
    • Feasibility and efficacy of high dose conformal radiotherapy for patients with locally advanced pancreatic carcinoma
    • H.M. Ceha, G. van Tienhoven, and D.J. Gouma Feasibility and efficacy of high dose conformal radiotherapy for patients with locally advanced pancreatic carcinoma Cancer 89 2000 2222 2229
    • (2000) Cancer , vol.89 , pp. 2222-2229
    • Ceha, H.M.1    Van Tienhoven, G.2    Gouma, D.J.3
  • 11
    • 4344626528 scopus 로고    scopus 로고
    • Phase II study of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer
    • T. Okusaka, Y. Ito, and H. Ueno Phase II study of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer Br J Cancer 91 2004 673 677
    • (2004) Br J Cancer , vol.91 , pp. 673-677
    • Okusaka, T.1    Ito, Y.2    Ueno, H.3
  • 12
    • 33750713641 scopus 로고    scopus 로고
    • Evaluation of acute intestinal toxicity in relation to the volume of irradiated small bowel in patients treated with concurrent weekly gemcitabine and radiotherapy for locally advanced pancreatic cancer
    • Y. Ito, T. Okusaka, and Y. Kagami Evaluation of acute intestinal toxicity in relation to the volume of irradiated small bowel in patients treated with concurrent weekly gemcitabine and radiotherapy for locally advanced pancreatic cancer Anticancer Res 26 Suppl. 5B 2006 3755 3759
    • (2006) Anticancer Res , vol.26 , Issue.SUPPL. 5B , pp. 3755-3759
    • Ito, Y.1    Okusaka, T.2    Kagami, Y.3
  • 13
    • 78549293230 scopus 로고    scopus 로고
    • A dosimetric model of duodenal toxicity after stereotactic body radiotherapy for pancreatic cancer
    • J.D. Murphy, C. Christman-Skieller, and J. Kim A dosimetric model of duodenal toxicity after stereotactic body radiotherapy for pancreatic cancer Int J Radiat Oncol Biol Phys 78 2010 1420 1426
    • (2010) Int J Radiat Oncol Biol Phys , vol.78 , pp. 1420-1426
    • Murphy, J.D.1    Christman-Skieller, C.2    Kim, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.